XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Available for Sale Securities
3 Months Ended
Sep. 30, 2023
Available for Sale Securities  
Available for Sale Securities

Note 3:  Available for Sale Securities

The amortized cost, gross unrealized gains, gross unrealized losses, ACL, and approximate fair value of securities available for sale consisted of the following:

September 30, 2023

 

 

Gross

 

Gross

 

Allowance

Estimated

 

Amortized

 

Unrealized

 

Unrealized

 

for

 

Fair

(dollars in thousands)

    

Cost

    

Gains

    

Losses

    

Credit Losses

    

Value

Debt and equity securities:

Obligations of states and political subdivisions

$

44,905

$

2

$

(3,710)

$

$

41,197

Corporate obligations

35,740

36

(2,640)

33,136

Asset backed securities

66,764

1,332

(454)

67,642

Other securities

 

2,662

 

28

 

(48)

 

 

2,642

Total debt and equity securities

150,071

1,398

(6,852)

144,617

Mortgage-backed securities (MBS) and collateralized mortgage obligations (CMOs):

Residential MBS issued by governmental sponsored enterprises (GSEs)

95,058

240

(8,905)

86,393

Commercial MBS issued by GSEs

61,188

(8,123)

53,065

CMOs issued by GSEs

131,090

(9,967)

121,123

Total MBS and CMOs

 

287,336

 

240

 

(26,995)

 

260,581

Total AFS securities

$

437,407

$

1,638

$

(33,847)

$

$

405,198

June 30, 2023

 

 

Gross

 

Gross

Allowance

Estimated

 

Amortized

 

Unrealized

 

Unrealized

 

for

 

Fair

(dollars in thousands)

    

Cost

    

Gains

    

Losses

    

Credit Losses

    

Value

Debt and equity securities:

Obligations of states and political subdivisions

$

45,285

$

20

$

(2,737)

$

$

42,568

Corporate obligations

35,700

19

(3,181)

32,538

Asset backed securities

67,897

1,274

(545)

68,626

Other securities

3,587

 

39

 

(56)

 

3,570

Total debt and equity securities

152,469

1,352

(6,519)

147,302

Mortgage-backed securities (MBS) and collateralized mortgage obligations (CMOs):

Residential MBS issued by governmental sponsored enterprises (GSEs)

97,612

122

(7,610)

90,124

Commercial MBS issued by GSEs

60,333

11

(6,959)

53,385

CMOs issued by GSEs

135,202

9

(8,468)

126,743

Total MBS and CMOs

 

293,147

 

142

 

(23,037)

 

 

270,252

Total AFS securities

$

445,616

$

1,494

$

(29,556)

$

$

417,554

The amortized cost and estimated fair value of investment and mortgage-backed securities, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

September 30, 2023

 

Amortized

 

Estimated

(dollars in thousands)

    

Cost

    

Fair Value

Within one year

$

2,465

$

2,459

After one year but less than five years

 

27,412

 

26,235

After five years but less than ten years

 

56,993

 

53,581

After ten years

 

63,201

 

62,342

Total investment securities

 

150,071

 

144,617

MBS and CMOs

 

287,336

 

260,581

Total AFS securities

$

437,407

$

405,198

The carrying value of investment and mortgage-backed securities pledged as collateral to secure public deposits amounted to $261.0 million and $253.9 million at September 30, 2023 and June 30, 2023, respectively. The securities pledged consist of marketable securities, including $140.9 million and $129.2 million of Mortgage-backed Securities, $91.8 million and $94.8 million of Collateralized Mortgage Obligations, $25.2 million and $26.5 million of State and Political Subdivisions Obligations, and $3.1 million and $3.4 million of Other Securities at September 30, 2023 and June 30, 2023, respectively.

The following tables show the Company’s investments’ gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for which an ACL has not been recorded at September 30, 2023 and June 30, 2023:

September 30, 2023

 

Less than 12 months

 

12 months or more

 

Total

 

Unrealized

 

Unrealized

 

Unrealized

(dollars in thousands)

    

Fair Value

    

Losses

    

Fair Value

    

Losses

    

Fair Value

    

Losses

Obligations of state and political subdivisions

$

9,443

$

236

$

30,959

$

3,474

$

40,402

$

3,710

Corporate obligations

14,235

724

16,015

1,916

30,250

2,640

Asset backed securities

18,683

180

705

274

19,388

454

Other securities

1,546

48

1,546

48

MBS and CMOs

 

85,241

 

2,146

 

146,151

 

24,849

 

231,392

 

26,995

Total AFS securities

$

127,602

$

3,286

$

195,376

$

30,561

$

322,978

$

33,847

June 30, 2023

 

Less than 12 months

 

12 months or more

 

Total

 

Unrealized

 

Unrealized

 

Unrealized

(dollars in thousands)

    

Fair Value

    

Losses

    

Fair Value

    

Losses

    

Fair Value

    

Losses

Obligations of state and political subdivisions

$

11,574

$

184

$

26,763

$

2,553

$

38,337

$

2,737

Corporate obligations

14,709

1,074

13,821

2,107

28,530

3,181

Asset backed securities

22,628

263

698

282

23,326

545

Other securities

1,970

11

350

45

2,320

56

MBS and CMOs

 

87,354

 

1,525

 

145,673

 

21,512

 

233,027

 

23,037

Total AFS securities

$

138,235

$

3,057

$

187,305

$

26,499

$

325,540

$

29,556

Obligations of state and political subdivisions. The unrealized losses on the Company’s investments in obligations of state and political subdivisions include 23 individual securities which have been in an unrealized loss position for less than 12 months and 64 individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is likely that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

Corporate and other Obligations. The unrealized losses on the Company’s investments in corporate obligations include 13 individual securities which have been in an unrealized loss position for less than 12 months and 14 individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are

of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

Asset-Backed securities. The unrealized losses on the Company’s investments in asset-backed securities includes six individual securities which has been in an unrealized loss position for less than 12 months and two individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized loss was caused by variations in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

MBS and CMOs. As of September 30, 2023, the unrealized losses on the Company’s investments in MBS and CMOs include 25 individual securities which have been in an unrealized loss position for less than 12 months, and 124 individual securities which have been in an unrealized loss position for 12 months or more. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is likely that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

The Company does not believe that any individual unrealized loss as of September 30, 2023, is the result of a credit loss. However, the Company could be required to recognize an ACL in future periods with respect to its available for sale investment securities portfolio.

Credit losses recognized on investments.  There were no credit losses recognized in income and other losses or recorded in other comprehensive loss for the three-month periods ended September 30, 2023 and 2022.